Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Kit Screens for Neurite Outgrowth Neurotoxin Inducers and Inhibitors

By HospiMedica staff writers
Posted on 20 Aug 2007
A new assay kit uses high-content screening for imaging and analysis of neurite outgrowth and neuronal cell morphology.

The kit utilizes high-quality, validated, target-specific detection reagents for profiling in a variety of species, including human, mouse, and rat. More...
Large-scale screening is simplified because the assay reagents are stable for 24-hours at room temperature.

The primary antibody is immunofluorescence-based to specifically label neurites and neuronal cell bodies in heterogeneous cell populations. High sensitivity-generating images with high signal-to-background ratios facilitate subsequent high content analysis, making the kit suitable for screening both inducers and inhibitors of neurite outgrowth neurotoxins.

Developed by Millipore corp. (Billerca, MA, USA), the new kit is called the Neurite Outgrowth assay. It is the newest assay kit in Millipore's drug discovery product line.

Millipore's Bioscience Division provides tools, services, and biologic reagents for LifeSciences and supports the discovery and development of new pharmaceuticals. Its product portfolio was enhanced in 2006 by the addition of the Chemicon, Upstate, and Linco product lines.


Related Links:
Millipore

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Wound Irrigation Solution
Prontosan®
Vessel Sealing Instrument
ERGOseal
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image Credit: Adobe Stock

New ECG Foundation Model Enables Broad Cardiac Diagnosis and Risk Prediction

Electrocardiograms are central to cardiovascular decision-making, but conventional artificial intelligence models are often trained for narrow tasks, such as detecting a single arrhythmia.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.